Definition, Diagnostic Criteria & Classification

Question	Answer
1. Detail the clinical differences between Wilms Tumor and Neuroblastoma at the bedside.
2. Detail the NWTS / COG Surgical Staging System for Wilms Tumor.	- Stage I ($40-45\%$): Tumor limited strictly to kidney; capsule intact; no vascular invasion beyond renal parenchyma; completely resected with negative margins. - Stage II ($20\%$): Tumor extends beyond kidney (into perirenal fat, renal sinus, or renal vein/IVC) but is completely resected with clear margins; no nodal metastasis. - Stage III ($20-25\%$): Residual non-hematogenous tumor confined to abdomen: positive surgical margins, abdominal nodal metastasis, peritoneal implants, or intraoperative tumor spillage / rupture. - Stage IV ($10\%$): Hematogenous distant metastases (Lungs is #1, followed by Liver and Bone). - Stage V ($5\%$): Bilateral renal involvement at initial diagnosis.
3. Contrast the COG / NWTS vs SIOP management philosophy for Wilms Tumor.	- COG / NWTS Philosophy (North America / India): UPFRONT RADICAL NEPHRECTOMY followed by risk-adapted adjuvant chemotherapy and radiation. - Advantages: Accurate histological classification before chemotherapy alterations; definitive nodal sampling; intact genetic biomarker analysis ($1p/16q$ LOH). - SIOP Philosophy (Europe): PREOPERATIVE CHEMOTHERAPY (Vincristine + Dactinomycin x 4 weeks) followed by delayed nephrectomy. - Advantages: Shrinks large tumors, hardens the pseudo-capsule, and significantly reduces intraoperative tumor spillage/rupture rates from $20\%$ down to $<5\%$.
4. What are the unfavorable histological and genetic markers in Wilms Tumor?	- Unfavorable Histology (Anaplasia, ~10%): Characterized by marked nuclear enlargement ($>3\times$), hyperchromatism, and multipolar mitotic figures (driven by somatic $TP53$ mutations); confers chemoresistance. - Unfavorable Genetic Biomarkers: Combined Loss of Heterozygosity (LOH) at chromosomes $1p$ and $16q$. Patients with $1p/16q$ LOH have significantly higher relapse rates and require intensified three-drug chemotherapy.
5. VIVA TRAP: Why is repeated or forceful palpation of a suspected Wilms tumor strictly CONTRAINDICATED?	The pseudo-capsule of Wilms tumor is extremely thin, tense, and fragile. Excessive or repeated palpation can cause capsule rupture and spillage of malignant cells into the peritoneal cavity. Intraoperative or pre-operative spillage immediately upstages a resectable Stage I or II tumor into Stage III Disease, necessitating whole-abdominal external beam radiation and intensive 3-drug chemotherapy, carrying long-term risks of bowel obstruction, radiation-induced second neoplasms, and scoliosis!

Pathophysiology & Therapeutics

Question	Answer
6. Why does a child with Wilms tumor develop Systemic Hypertension?	Present in $25-30\%$ of children with Wilms tumor through two mechanisms: 1) Renal Arteriolar Compression: The expanding intrarenal mass compresses adjacent normal renal parenchymal arterioles, producing localized renal tissue ischemia. Ischemic juxtaglomerular cells hypersecrete Renin, activating the Renin-Angiotensin-Aldosterone System (RAAS). 2) Direct Renin Secretion: In a minority of cases, tumor blastemal cells directly synthesize and secrete renin.
7. What are the classical Syndromes associated with Wilms Tumor?	1) WAGR Syndrome: Deletion of chromosome $11p13$ involving $WT1$ and $PAX6$ genes: Wilms tumor ($50\%$ risk), Aniridia, Genitourinary anomalies (cryptorchidism, hypospadias), and Retardation (developmental delay). 2) Denys-Drash Syndrome (DDS): Point mutation in $WT1$ zinc-finger exon: Triad of Wilms tumor ($90\%$), male pseudohermaphroditism ($46,XY$ DSD), and early-onset Diffuse Mesangial Sclerosis (nephrotic syndrome progressing to ESKD by age 3). 3) Beckwith-Wiedemann Syndrome (BWS): Imprinting defect on chromosome $11p15.5$ ($IGF2$ overexpression): Hemihypertrophy, macroglossia, omphalocele, neonatal hypoglycemia, and high risk of Wilms tumor and hepatoblastoma (requires abdominal USG screening every 3 months until age 8).
8. Detail the adjuvant chemotherapy regimens for Wilms Tumor.	- Stage I and II (Favorable Histology): Two-Drug Regimen: IV Vincristine ($1.5\text{ mg/m}^2$) + IV Dactinomycin ($0.045\text{ mg/kg}$) for 18 weeks. Radiotherapy is completely omitted! Cure rate exceeds $95\%$. - Stage III (Favorable Histology): Three-Drug Regimen: Vincristine + Dactinomycin + Doxorubicin ($45\text{ mg/m}^2$) for 24 weeks PLUS Flank Radiotherapy ($10.8\text{ Gy}$). - Stage IV: Three-Drug Regimen + Whole-Lung Radiotherapy ($12\text{ Gy}$).

VIVA TRAPs & Counter-Questions

Question

Answer

9. VIVA TRAP: What is the "Claw Sign" on abdominal imaging?

On contrast-enhanced CT or ultrasound, the Claw Sign is created when the normal, non-tumorous renal parenchyma forms a sharp, curved beak or rim capping the margin of an expanding renal mass. Its presence confirms that the tumor originates FROM WITHIN the renal parenchyma (e.g., Wilms tumor), whereas an extrarenal mass (Neuroblastoma) merely displaces the intact kidney downward and outward without a claw sign!

10. Counter-Question Chain: "What is Stage MS (formerly Stage 4S) Neuroblastoma, and why is its management unique?"

- Definition: Occurs in infants $<18\text{ months}$ with localized primary tumor (L1/L2) with metastases strictly restricted to skin, liver, and/or bone marrow ($<10\%$ marrow involvement, without cortical bone metastasis).
- Unique Biology: Exhibits high rates of spontaneous regression or differentiation into benign ganglioneuroma due to delayed programmed cell death (apoptosis) triggered by NGF/TrkA expression.
- Management: Conservative supportive observation without cytotoxic chemotherapy unless massive hepatomegaly compromises respiration or renal perfusion!